- Home
- STHO vs GNTA Comparison
STHO vs GNTA Comparison
Compare STHO & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STHO
- GNTA
- Stock Information
- Founded
- STHO N/A
- GNTA 2014
- Country
- STHO United States
- GNTA Italy
- Employees
- STHO N/A
- GNTA N/A
- Industry
- STHO Real Estate
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STHO Real Estate
- GNTA Health Care
- Exchange
- STHO Nasdaq
- GNTA Nasdaq
- Market Cap
- STHO 89.7M
- GNTA 81.2M
- IPO Year
- STHO N/A
- GNTA 2021
- Fundamental
- Price
- STHO $7.75
- GNTA $3.78
- Analyst Decision
- STHO
- GNTA Strong Buy
- Analyst Count
- STHO 0
- GNTA 1
- Target Price
- STHO N/A
- GNTA $25.00
- AVG Volume (30 Days)
- STHO 150.9K
- GNTA 26.5K
- Earning Date
- STHO 08-05-2025
- GNTA 01-01-0001
- Dividend Yield
- STHO N/A
- GNTA N/A
- EPS Growth
- STHO N/A
- GNTA N/A
- EPS
- STHO N/A
- GNTA N/A
- Revenue
- STHO $113,297,000.00
- GNTA N/A
- Revenue This Year
- STHO N/A
- GNTA N/A
- Revenue Next Year
- STHO N/A
- GNTA N/A
- P/E Ratio
- STHO N/A
- GNTA N/A
- Revenue Growth
- STHO N/A
- GNTA N/A
- 52 Week Low
- STHO $6.06
- GNTA $2.74
- 52 Week High
- STHO $14.50
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- STHO 49.93
- GNTA 50.99
- Support Level
- STHO $7.68
- GNTA $3.51
- Resistance Level
- STHO $8.09
- GNTA $3.86
- Average True Range (ATR)
- STHO 0.22
- GNTA 0.19
- MACD
- STHO -0.05
- GNTA 0.01
- Stochastic Oscillator
- STHO 30.43
- GNTA 55.10
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.